|Bid||0.00 x 1100|
|Ask||0.00 x 800|
|Day's range||64.82 - 66.19|
|52-week range||55.81 - 120.00|
|Beta (5Y monthly)||0.08|
|PE ratio (TTM)||N/A|
|Earnings date||06 Dec 2021 - 10 Dec 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||93.93|
Chewy (NYSE: CHWY), a one-time market darling, is falling out of favor with the market as of late. The fall from grace can be attributed to several reasons, including but not limited to: rising costs for labor and advertising, reopening economies, and supply shortages. As a result, the costs to get people to work for Chewy are rising.
It seems that some investors have dismissed telemedicine provider Teladoc Health (NYSE: TDOC) as a pandemic stock in recent months -- passing on it as vaccinations accelerate and many people go back to work, school, and social activities in person. Concerns about Teladoc's long-term prospects have been evident in the stock's fluctuations in recent months. There's no doubt 2020 was a big year for Teladoc.
Chewy (NYSE: CHWY) was a pandemic success story, but the online pet products seller still has a long growth runway. The company's autoship model is also helping build customer loyalty and move the company closer to profitabiltiy. In this segment of Beat and Raise recorded on Sept. 1, Fool contributors Jeremy Bowman and Jason Hall discuss those factors and more.